Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The Center for Biologics Evaluation and Research (CBER) history began with a horse named Jim, a vaccine-contamination scandal that prompted the Biologics Control Act of 1902. CBER is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Dr. Karen Midthun. CBER is responsible for assuring the safety, purity, potency, and effectiveness of biologics and related products such as vaccines, live biotherapeutics, blood products, and cell, tissue, and gene therapies. Not all biologics are regulated by CBER. Monoclonal antibodies and other therapeutic proteins are regulated by the FDA Center for Drug Evaluation and Research (CDER).
The following is the list of scholars from Center for Biologics Evaluation and Research who contributed and/or serves as editors for one or more OMICS International journals and conferences
The following is the list of proceedings by scholars from Center for Biologics Evaluation and Research that are published in OMICS International journals and conferences.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi